Lufthansa has launched a pilot testing program on its Munich-Hamburg routes. On two daily flights (LH2058; LH2059), passengers at the airport are tested for COVID-19 with the rapid antigen test. Once completed, customers receive their results within a short time period by push message and e-mail.
All guests on the first flight in the program, on November 12th, tested negative and were able to start their journey to Hamburg. All test results on the second daily flight, LH2059 from Hamburg to Munich, were also negative.
In close cooperation with the Munich and Hamburg airports, as well as with the biotech companies Centogene and the Medicover Group’s medical care center, MVZ Martinsried, the airline is offering its customers the opportunity to be tested for COVID-19, free-of-charge, before the departure of these two daily flights.
Passengers who do not wish to be tested are transferred to an alternative flight at no additional cost. Only if the result is negative, the boarding pass will be activated and access to the gate will be granted.
With Lufthansa taking care of the entire rapid test procedure, there are no extra costs for the passenger. All they have to do is register in advance and allow a little more time before departure. Alternatively, passengers can present a negative PCR test not older than 48 hours at departure to board these special flights.
Ola Hansson, CEO Lufthansa Hub Munich, said: “We want to again expand the worldwide travel options for our customers while maintaining the highest hygiene and safety standards. Successful testing of entire flights can be an important key to this. With the test flights we have successfully launched today, we are gaining important knowledge and experience in handling rapid tests.”
Jost Lammers, CEO of Flughafen München GmbH, added: “The trial run with the rapid antigen tests on selected Lufthansa flights is a positive and important signal for the industry. In addition to the extensive hygiene measures that airports and airlines already have in place for passengers, these tests offer an additional level of safety. This could mean that in the future – if the appropriate international agreements are reached – cross-border travel without the obligatory quarantine obligation could once again be possible”.